You are now leaving helsinn.com

Please click 'Continue to external site' if you want to continue.

Sergio Cantoreggi

Group Chief Scientific Officer, Global Head of R&D

Biography

  • +20 yrs of experience in the pharmaceutical business
  • Joined Helsinn Healthcare in 2000 as drug development scientist and was appointed Head of R&D in 2005
  • Prior to Helsinn, he worked as toxicologist and regulatory scientist for Sandoz and Novartis
  • MS in Chemistry and PhD in Natural Sciences at ETH in Zürich, followed by two post-doctoral fellowships in Switzerland and in the U.S.

Helsinn’s Senior Executive Committee Team

Riccardo Braglia

Executive Chairman

Konrad Wilson

Group Chief Financial Officer

Melanie Rolli

Group Chief Operating Officer

Giorgio Calderari

Group CEO & Board Member

Matteo Missaglia

Group General Counsel, Group Chief Legal Officer

Sergio Cantoreggi

Group Chief Scientific Officer, Global Head of R&D

Georg Büchner

Group Chief Business Officer

Roberta Cannella

Group Chief Manufacturing Officer